These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9723442)

  • 21. Chemical modification of rapamycin: the discovery of SDZ RAD.
    Sedrani R; Cottens S; Kallen J; Schuler W
    Transplant Proc; 1998 Aug; 30(5):2192-4. PubMed ID: 9723437
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD.
    Jacobsen W; Serkova N; Hausen B; Morris RE; Benet LZ; Christians U
    Transplant Proc; 2001; 33(1-2):514-5. PubMed ID: 11266932
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro metabolic study of temsirolimus: preparation, isolation, and identification of the metabolites.
    Cai P; Tsao R; Ruppen ME
    Drug Metab Dispos; 2007 Sep; 35(9):1554-63. PubMed ID: 17540708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
    Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
    Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats.
    Crowe A; Bruelisauer A; Duerr L; Guntz P; Lemaire M
    Drug Metab Dispos; 1999 May; 27(5):627-32. PubMed ID: 10220493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat.
    Sattler M; Guengerich FP; Yun CH; Christians U; Sewing KF
    Drug Metab Dispos; 1992; 20(5):753-61. PubMed ID: 1385058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of novel rapamycin structures by microbial manipulations.
    Nishida H; Sakakibara T; Aoki F; Saito T; Ichikawa K; Inagaki T; Kojima Y; Yamauchi Y; Huang LH; Guadliana MA
    J Antibiot (Tokyo); 1995 Jul; 48(7):657-66. PubMed ID: 7649865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients.
    Neumayer HH; Paradis K; Korn A; Jean C; Fritsche L; Budde K; Winkler M; Kliem V; Pichlmayr R; Hauser IA; Burkhardt K; Lison AE; Barndt I; Appel-Dingemanse S
    Br J Clin Pharmacol; 1999 Nov; 48(5):694-703. PubMed ID: 10594471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
    Schuurman HJ; Schuler W; Ringers J; Jonker M
    Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of a novel route of extraction of sirolimus in human small intestine: roles of metabolism and secretion.
    Paine MF; Leung LY; Lim HK; Liao K; Oganesian A; Zhang MY; Thummel KE; Watkins PB
    J Pharmacol Exp Ther; 2002 Apr; 301(1):174-86. PubMed ID: 11907172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and validation of the MS/MS fragmentation patterns of the macrolide immunosuppressant everolimus.
    Boernsen KO; Egge-Jacobsen W; Inverardi B; Strom T; Streit F; Schiebel HM; Benet LZ; Christians U
    J Mass Spectrom; 2007 Jun; 42(6):793-802. PubMed ID: 17511017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of the rapamycin-derivate SDZ RAD on the healing of airway anastomoses.
    Dutly AE; Gaspert A; Inci I; Schneiter D; Korom S; Weder W
    Eur J Cardiothorac Surg; 2003 Jul; 24(1):154-8; discussion 158. PubMed ID: 12853061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.
    Lampen A; Zhang Y; Hackbarth I; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1104-12. PubMed ID: 9618413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of in vitro metabolites of trimethoprim and diaveridine in pig liver microsomes by liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry.
    Liu ZY; Wu Y; Sun ZL; Wan L
    Biomed Chromatogr; 2012 Sep; 26(9):1101-8. PubMed ID: 22161732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
    Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
    Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
    [No Abstract]   [Full Text] [Related]  

  • 40. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.